SMMIP Bio-Based Solvents grant writing: Ayming works for a success fee
- Centre for Process Innovation
- North East
- Direct
- 26 March 2026 to 25 March 2027
The Centre for Process Innovation (CPI) agreed a success fee with Ayming UK Limited for grant writing on the SMMIP Bio-Based Solvents project.
GSK chose Ayming as bid consultant while GSK led the consortium, before CPI came on board. When CPI joined, it agreed to keep Ayming as the project's consultant.
CPI awarded the £35,000 fee directly in March 2026. The contract runs to March 2027.
Contract ends March 2027
- What
- Funding bid preparation
- Supplier
- Ayming UK Limited
- Value
- £35,000
- How it was bought
- Direct
- Dates and next
- Mar 2026 to Mar 2027